ZUMRAD Trademark

Trademark Overview

On Monday, September 12, 2016, a trademark application was filed for ZUMRAD with the United States Patent and Trademark Office. The USPTO has given the ZUMRAD trademark a serial number of 87167627. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, March 10, 2020. This trademark is owned by Pfizer Inc.. The ZUMRAD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
zumrad

General Information

Serial Number87167627
Word MarkZUMRAD
Filing DateMonday, September 12, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, March 10, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, May 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, May 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, March 2, 2020ASSIGNED TO EXAMINER
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2019EXTENSION 5 GRANTED
Friday, September 6, 2019EXTENSION 5 FILED
Tuesday, September 10, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 6, 2019TEAS EXTENSION RECEIVED
Wednesday, August 14, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2019EXTENSION 4 GRANTED
Friday, February 15, 2019EXTENSION 4 FILED
Friday, February 15, 2019TEAS EXTENSION RECEIVED
Wednesday, August 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 20, 2018EXTENSION 3 GRANTED
Monday, August 20, 2018EXTENSION 3 FILED
Monday, August 20, 2018TEAS EXTENSION RECEIVED
Saturday, February 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2018EXTENSION 2 GRANTED
Thursday, February 8, 2018EXTENSION 2 FILED
Thursday, February 8, 2018TEAS EXTENSION RECEIVED
Friday, July 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 19, 2017EXTENSION 1 GRANTED
Wednesday, July 19, 2017EXTENSION 1 FILED
Wednesday, July 19, 2017TEAS EXTENSION RECEIVED
Wednesday, March 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2016ASSIGNED TO EXAMINER
Thursday, September 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 15, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

zumrad preparations pharmaceutical dysfunction treatment disorders erectile diseases urological urogenital sexual